Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study Pharmaceutical Investing
SELLAS Life Sciences Announces Completion of Enrollment in Phase 2 Clinical Study of Nelipepimut-S Pharmaceutical Investing
Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (Elunate) Pharmaceutical Investing
Lexaria Bioscience Submits Application to Health Canada for Research License and Appoints Chief Legal Officer Cannabis Investing News
Naturally Splendid and Wahupta Ventures Inc. Complete Further Financings and Proceed with Processing License Cannabis Investing News
